Ocular Disease-Focused Biotechs Eye Follow-On Offerings
Two eye-focused biotechs — New York-based Ohr Pharmaceutical Inc. and California-based Avalanche Biotechnologies Inc. — laid out plans for follow-on offerings Monday, targeting investors still hungry to gobble up life sciences...To view the full article, register now.
Already a subscriber? Click here to view full article